Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors

NCT01188499 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Birinapant

Sponsor

TetraLogic Pharmaceuticals